ACHN Financial Facts
Total operating expenses: 21.55MNet loss: -20.73M
See Full Income Statement
Long-term debt: 55K
Total liabilities: 13.98M
See Full Balance Sheet
Achillion Pharmaceuticals, Inc. (ACHN) Earnings
|
Expand Research on ACHN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/19  |
Q418 | -$0.12 | N/A | N/A | $12.2M | $15.4M | N/A |  | | Details | |
| 5/2/18 |
Q118 | -$0.15 | -$0.14 | -$0.01 | N/A | N/A | = | | | Details | |
| 2/22/18 |  |
Q417 | -$0.17 | -$0.16 | -$0.01 | N/A | N/A | = | | | Details |
| 8/8/17 | Q217 | -$0.16 | -$0.16 | $0.00 | N/A | N/A | = | | | Details | |
| 11/3/16 |
Q316 | -$0.15 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 5/3/16 | Q116 | -$0.13 | -$0.14 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 8/10/15 | Q215 | -$0.25 | -$0.18 | -$0.07 | N/A | N/A | N/A | | | Details | |
| 5/7/15 | Q115 | -$0.17 | -$0.22 | +$0.05 | N/A | N/A | N/A | | | Details |
